Health & Fitness
Health and Fitness
Health and Fitness 
Mon, February 28, 2011
BIOLASE Announces Successful Showing of Waterlase(R) iPlus(TM) All-Tissue Laser at 146th Chicago Dental Society Midwinter Meeti
IRVINE, CA--(Marketwire - February 28, 2011) - BIOLASE Technology, Inc. (
Federico Pignatelli, Chairman and CEO, commented, "BIOLASE has returned to its highest level of orders at the Chicago Midwinter Dental Show since 2007 when the Company enjoyed annual sales of $67 million. Over three days at the show, the BIOLASE booth was visited by many current and former luminaries, as well as dozens of current customers, who showed a high level of interest in the Waterlase® iPlus™ system. The Waterlase iPlus system features a dual wavelength by combining the handheld and ergonomic 940 nm iLase™ system with the 2780 nm Waterlase iPlus. The Waterlase iPlus has further advanced laser dentistry with the introduction of new patented laser technology that allows for cutting speeds that surpass both the dental drill and any other dental laser on the market. The common theme from those that visited the booth was that the Waterlase iPlus system gives dentists the ability to cut tooth structure as fast as their dental drills without micro-fractures, the need for shots, or the danger of cross contamination, which is a risk when using a dental bur."
Pignatelli continued, "BIOLASE wrote 22 sales orders for the all-tissue Waterlase iPlus laser, its newly released flagship product. These sales orders were based on a retail price of $57,900 for the iPlus System with three levels of training options available to the dentists at an additional cost ranging from $2,795 for the Silver Package to $4,995 for the Platinum Package. Dentists were allowed to select the training package that is best suited for their needs. The final number of orders of Waterlase iPlus systems ended well above the 15 units internally forecasted for the Chicago Midwinter Dental Show."
Pignatelli added, "Due to the strong initial interest and demand since its recent launch at the Yankee Dental Congress 36 in Boston on January 27th, where we received the first orders, the price of the Waterlase iPlus system has been raised by $3,000 and was offered at the Chicago Midwinter Dental Show at its full price, contrary to the traditional discounts expected at trade shows. BIOLASE's plan for the current quarter is to manufacture 80 systems and it appears that we may have a realistic chance to end the quarter with a backlog of orders. It is certainly shaping as what could be our most successful product launch of an all-tissue laser in the history of the Company."
BIOLASE also received orders for the rest of its dental product line, such as the all-tissue Waterlase MD Turbo™ and its Diode family of products, which includes the EzLase™, the Company's Total Diode Solution, and the revolutionary handheld and battery operated iLase system.
About BIOLASE Technology, Inc.
BIOLASE Technology, Inc., the World's leading Dental Laser company, is a medical technology company that develops, manufactures and markets dental lasers and also distributes and markets dental imaging equipment, products that are focused on technologies that advance the practice of dentistry and medicine. The Company's laser products incorporate patented and patent pending technologies designed to provide clinically superior performance with less pain and faster recovery times. Its imaging products provide cutting-edge technology at competitive prices to deliver the best results for dentists and patients. BIOLASE's principal products are dental laser systems that perform a broad range of dental procedures, including cosmetic and complex surgical applications, and a full line of dental imaging equipment. Other products under development address ophthalmology and other medical and consumer markets.
For updates and information on laser and Waterlase dentistry, find BIOLASE at [ http://www.biolase.com ], Twitter at [ http://twitter.com/GoWaterlase ], and YouTube at [ http://www.youtube.com/user/Rossca08 ].
This press release may contain forward-looking statements within the meaning of safe harbor provided by the Securities Reform Act of 1995 that are based on the current expectations and estimates by our management. These forward-looking statements can be identified through the use of words such as "anticipates," "expects," "intends," "plans," "believes," "seeks," "estimates," "may," "will," and variations of these words or similar expressions. Forward-looking statements are based on management's current, preliminary expectations and are subject to risks, uncertainties and other factors which may cause the Company's actual results to differ materially from the statements contained herein, and are described in the Company's reports it files with the Securities and Exchange Commission, including its annual and quarterly reports. No undue reliance should be placed on forward-looking statements. Such information is subject to change, and we undertake no obligation to update such statements.